Chow, E. J., Doody, D. R., Wilkes, J. J., Becker, L. K., Chennupati, S., Morin, P. E., . . . Lyman, G. H. (2020). Adverse events among chronic myelogenous leukemia patients treated with tyrosine kinase inhibitors: A real-world analysis of health plan enrollees. Leuk Lymphoma.
シカゴスタイル引用形Chow, Eric J., David R. Doody, Jennifer J. Wilkes, Laura K. Becker, Shasank Chennupati, Pamela E. Morin, Lena E. Winestone, Henry J. Henk, , Gary H. Lyman. "Adverse Events Among Chronic Myelogenous Leukemia Patients Treated With Tyrosine Kinase Inhibitors: A Real-world Analysis of Health Plan Enrollees." Leuk Lymphoma 2020.
MLA引用形式Chow, Eric J., et al. "Adverse Events Among Chronic Myelogenous Leukemia Patients Treated With Tyrosine Kinase Inhibitors: A Real-world Analysis of Health Plan Enrollees." Leuk Lymphoma 2020.